|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2017
Altenburg, Arwen F.; Sandt, Carolien E. van de; Li, Bobby W. S.; MacLoughlin, Ronan J.; Fouchier, Ron A. M.; Amerongen, Geert van; Volz, Asisa; Hendriks, Rudi W.; Swart, Rik L. de; Sutter, Gerd 
ORCID: https://orcid.org/0000-0001-6143-082X; Rimmelzwaan, Guus F. und Vries, Rory D. de
(2017):
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.
In: Scientific Reports, Bd. 7, 8580
[PDF, 8MB]
ORCID: https://orcid.org/0000-0001-6143-082X; Rimmelzwaan, Guus F. und Vries, Rory D. de
(2017):
Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo.
In: Scientific Reports, Bd. 7, 8580
[PDF, 8MB]
2009
Kreijtz, Joost H. C. M.; Suezer, Yasemin; Mutsert, Gerrie de; Amerongen, Geert van; Schwantes, Astrid; Brand, Judith M. A. van den; Fouchier, Ron A. M.; Löwer, Johannes; Osterhaus, Albert D. M. E.; Sutter, Gerd ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2009):
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
In: PLOS ONE 4(11), e7790 [PDF, 925kB]
ORCID: https://orcid.org/0000-0001-6143-082X und Rimmelzwaan, Guus F.
(2009):
MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.
In: PLOS ONE 4(11), e7790 [PDF, 925kB]